Great Lakes Advisors, LLC Dexcom Inc Transaction History

Great Lakes Advisors, LLC

$11.1 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$110.31 - $140.45 $3,860 - $4,915	-35 Reduced 0.84%	4,133 $468,000
Q1 2024 May 08, 2024	BUY	$114.22 - $140.1 $224,670 - $275,576	1,967 Added 89.37%	4,168 $578,000
Q4 2023 Feb 08, 2024	SELL	$75.49 - $124.16 $3,925 - $6,456	-52 Reduced 2.31%	2,201 $273,000
Q3 2023 Nov 07, 2023	SELL	$86.06 - $137.93 $25,990 - $41,654	-302 Reduced 11.82%	2,253 $210,000
Q1 2023 May 10, 2023	SELL	$104.0 - $122.92 $13,728 - $16,225	-132 Reduced 4.91%	2,555 $296,000
Q4 2022 Feb 09, 2023	SELL	$84.98 - $122.67 $1,699 - $2,453	-20 Reduced 0.74%	2,687 $304,000
Q3 2022 Nov 09, 2022	SELL	$76.35 - $94.18 $381 - $470	-5 Reduced 0.18%	2,707 $218,000
Q2 2022 Aug 09, 2022	BUY	$67.99 - $132.89 $134,416 - $262,723	1,977 Added 268.98%	2,712 $202,000
Q1 2022 May 06, 2022	SELL	$94.08 - $130.2 $14,676 - $20,311	-156 Reduced 17.51%	735 $376,000
Q4 2021 Feb 09, 2022	SELL	$129.87 - $162.82 $25,714 - $32,238	-198 Reduced 18.18%	891 $478,000
Q3 2021 Nov 09, 2021	SELL	$106.71 - $143.18 $119,621 - $160,504	-1,121 Reduced 50.72%	1,089 $596,000
Q2 2021 Aug 11, 2021	SELL	$80.99 - $107.93 $568,954 - $758,208	-7,025 Reduced 76.07%	2,210 $944,000
Q1 2021 May 03, 2021	BUY	$84.79 - $104.74 $301,089 - $371,931	3,551 Added 62.47%	9,235 $3.32 Million
Q4 2020 Feb 09, 2021	BUY	$78.0 - $104.5 $379,626 - $508,601	4,867 Added 595.72%	5,684 $2.1 Million
Q3 2020 Nov 04, 2020	BUY	$95.51 - $112.95 $1,719 - $2,033	18 Added 2.25%	817 $337,000
Q2 2020 Aug 07, 2020	SELL	$62.68 - $105.34 $9,276 - $15,590	-148 Reduced 15.63%	799 $324,000
Q1 2020 May 08, 2020	SELL	$47.79 - $75.63 $11,469 - $18,151	-240 Reduced 20.22%	947 $255,000
Q4 2019 Feb 07, 2020	SELL	$36.62 - $57.29 $41,563 - $65,024	-1,135 Reduced 48.88%	1,187 $260,000
Q3 2019 Nov 06, 2019	SELL	$35.53 - $43.8 $11,547 - $14,234	-325 Reduced 12.28%	2,322 $347,000
Q2 2019 Aug 05, 2019	BUY	$27.84 - $38.92 $11,219 - $15,684	403 Added 17.96%	2,647 $397,000
Q1 2019 May 07, 2019	BUY	$28.07 - $38.18 $62,989 - $85,675	2,244 New	2,244 $267,000
Q4 2018 Feb 13, 2019	SELL	$26.99 - $37.37 $45,856 - $63,491	-1,699 Closed	0 $0
Q3 2018 Nov 30, 2018	BUY	$23.35 - $36.72 $39,671 - $62,387	1,699 New	1,699 $243,000

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Lakes Advisors, LLC with notifications on news.

Account